AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 275: R315-R322, 1998;
0363-6119/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, L.
Right arrow Articles by Wei, J. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, L.
Right arrow Articles by Wei, J. Y.
Vol. 275, Issue 1, R315-R322, July 1998

Bcl-2 and Bax expression in adult rat hearts after coronary occlusion: age-associated differences

Lixin Liu, Gohar Azhar, Wei Gao, Xiaomin Zhang, and Jeanne Y. Wei

Division on Aging, Harvard Medical School and Gerontology Division, Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02215

    ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

It has been reported that programmed cell death (apoptosis) occurs during myocardial infarction. The influence of age on programmed cell death or DNA fragmentation after coronary occlusion has not been extensively characterized. To test the hypothesis that there are age-related differences in susceptibility to DNA fragmentation during ischemia-infarction, we studied DNA fragmentation in young adult and old male F344 rat hearts after acute coronary artery occlusion. Hearts were studied at 1, 3, and 5 h and 1 and 7 days after coronary ligation. The percentage of apoptotic cells was determined by the in situ end-labeling technique, and internucleosomal fragmentation (DNA laddering) pattern was also analyzed. Our results show that 1) DNA fragmentation began earlier and peaked earlier in the old compared with young adult hearts during infarction; 2) there was heightened expression of both Bcl-2 and Bax in the old hearts at baseline; and 3) the Bcl-2-to-Bax ratio was higher in the older heart after coronary ligation. These results suggest that, compared with the young adult heart, the aged heart may be more susceptible to ischemia-induced DNA fragmentation.

apoptosis; programmed cell death; infarction; aging; cardiomyocytes; ischemia

    INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

APOPTOSIS is a form of programmed cell death that has been described in different cells at various stages of development in humans and animals (16, 21, 29, 30). Although the stimuli that cause apoptosis may in some cases not differ markedly from those that cause necrosis, there are significant differences in the molecular mechanisms governing these two forms of cell death and the associated morphological appearances (11, 16, 21, 29, 30). The most striking difference between necrosis and apoptosis is that, with apoptosis, there is no evidence of inflammation, and in most instances, the DNA is cleaved into multiple fragments of 200 bp or more (10, 11, 16, 29, 30). Apart from other morphological differences, the distinct DNA laddering pattern in apoptosis usually distinguishes it from necrosis, in which it is diffuse and nonspecific (10).

Recently, several studies of apoptosis in the heart have been performed in humans and animals (1, 2, 5, 7, 10, 14, 22, 24, 26, 27). These studies have reported that there is significant and rapid apoptosis in response to myocardial ischemia, which often precedes necrosis. The findings highlight the importance of studying apoptosis and DNA fragmentation in the heart, since it may provide valuable information for improving our understanding of this potential new target for cardioprotective therapy.

Most myocardial infarctions occur in older persons, and the associated morbidity and mortality are higher with advancing age (17, 32). To better understand this age-associated difference, we sought to characterize the influence of age on DNA fragmentation in the heart after coronary occlusion. We studied hearts of young adult and old rats after acute left anterior descending coronary artery (LAD) ligation. Our results suggest that there is a highly significant age-related difference in DNA fragmentation at 3 and 5 h after infarction, with DNA fragmentation reaching a peak earlier in the old (3 h) vs. the young adult (5 h). Bcl-2 and Bax protein expression also showed age-associated differences. These findings suggest that the aged heart has a different time course of susceptibility to DNA fragmentation in that it occurs more rapidly in the old compared with the young adult heart.

    METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Animals studied. Young adult (6-8 mo, 350-400 g body wt) and senescent (22-24 mo, 350-400 g body wt) male F344 rats were obtained from Harlan Sprague Dawley (under National Institute on Aging contract, Indianapolis, IN). The animals were inspected for any signs of acute or chronic illness. Only those animals in excellent health and free of gross pathology were included in the study (total no. = 80).

Infarction model. Anesthesia was induced by using ketamine hydrochloride (40 mg/kg ip) and xylazine (10 mg/kg ip). Endotracheal intubation was performed under direct visualization. Controlled ventilation with room air was provided by using a rodent ventilator (Harvard Apparatus model 638). The heart was exposed through a left intercostal thoracotomy under sterile conditions, and the LAD was ligated by using a 7-0 silk suture. The appearance of cyanosis and bulging of the anterior left ventricle demonstrated successful coronary occlusion. A total of 80 animals were included in the study: 60 animals (30 young adult, 30 old) underwent LAD occlusion and 20 underwent sham operation. Animals were killed 1, 3, and 5 h and 1 and 7 days after coronary occlusion. Twenty (10 young adult, 10 old) sham-operated animals (with thoracotomy but without coronary ligation) served as controls.

Delineation of the ischemic-infarcted area of the heart was performed by injection with 1% Evans blue dye into the inferior vena cava when the animals were killed. The viable area stained blue, whereas the ischemic-infarcted area remained pale. The pale, ischemic area was separated from the blue, nonischemic area, and both portions of each heart were separately processed and analyzed for protein expression and DNA fragmentation.

Histology. After coronary occlusion, the experimental animals were killed at the time points listed above. Sham-operated controls (operated on, but ligature was not tied) were also killed at the same time points. The heart was quickly removed and washed in ice-cold PBS. Parts of the free wall of the left ventricle including the infarcted and peri-infarcted regions were fixed in 10% buffered neutral formaldehyde solution overnight at 4°C and then embedded in paraffin. Sections were cut to a 5-µm thickness. The slides were stained with hematoxylin and eosin. The sections of hearts from animals that were killed at 7 days were also stained with Masson trichrome.

Internucleosomal DNA fragmentation assay. Internucleosomal DNA fragmentation assay (DNA ladder pattern analysis) was performed. Briefly, tissues were homogenized in 5 ml of lysis buffer containing 10 mM Tris · HCl at pH 8.0 and 100 mM EDTA (TBE), SDS (0.5 ml), and RNase (Promega) and incubated at 37°C for 60 min. A second incubation was performed at 50°C for 3 h after the addition of proteinase K (100 µg/ml, Promega). The final incubation was completed in 1 M NaCl overnight at 4°C. The solution was then spun at 12,000 rpm for 20 min, and the supernatant was extracted twice with phenol and chloroform-isopropanol (49:1). DNA was precipitated in cold ethanol at -20°C. DNA (20 µg) was then loaded onto 1.6% agarose gel containing 0.5 µg/ml ethidium bromide, electrophoresed in 1 × TBE, and visualized under ultraviolet illumination.

In situ identification of nuclear DNA fragmentation in rat hearts. After being deparaffinized, the tissue sections were stained by using the in situ terminal deoxynucleotidyl transferase-mediated Nick end-labeling (TUNEL) method with the in situ ApopTag detection kit (Oncor, Gaithersburg, MD) to identify cells showing nuclear DNA fragmentation. The procedure is based on the method described by Schmitz et al. (28). Residues of digoxigenin nucleotide are catalytically added to the DNA by terminal deoxynucleotidyl transferase, an enzyme that catalyzes a template-independent addition of deoxyribonucleotide triphosphate to the 3'-OH ends of double- or single-stranded DNA. The anti-digoxigenin antibody fragment carries either a fluorescein or peroxidase antibody to the reaction site.

For negative controls of DNA fragmentation, sections were stained without terminal deoxynucleotidyl transferase. The sections of fluorescein-labeled tissue were also mounted under glass cover slips with a drop of staining buffer containing propidium iodide-Antifade (1:4, Oncor) to visualize all the nuclei (nonapoptotic and apoptotic). The sections stained for DNA fragmentation labeled with peroxidase were used for quantitative analysis. In a subset of six animals (3 adult, 3 old), double staining with mouse monoclonal anti-alpha -sarcomeric actin antibody (1:500 for 30 min at room temperature) was performed to identify the myocytes and to confirm that the DNA fragmentation occurred in the cardiac myocyte nuclei.

The percentage of ApopTag-labeled cells was determined with a microscope containing an eyepiece grid (×200 magnification). Ten microscopic fields per section were selected from within the ischemic region and twenty fields per section from the nonischemic region. In each field, 100 cells were counted in the ischemic region, and 200 cells were counted in the nonischemic region. The percentage of apoptotic cells was calculated for the ischemic and the nonischemic regions. A minimum of 5 slides per ischemic region and 25 slides per nonischemic region were used. The results from three different experiments were used to determine the means ± SD at each time point for each age group.

Protein extraction. The heart tissues were washed in cold PBS. They were then homogenized in lysis buffer [20 mM HEPES (pH 7.5), 150 mM NaCl, 1% NP-40, 0.1% SDS, 1 mM EDTA, and 1.0 mM DTT] with protease inhibitors (2 µg each of aprotinin, leupeptin, pepstatin A, and 0.5 mM phenylmethylsulfonyl fluoride), incubated on ice for 30 min, and centrifuged at 10,000 g at 4°C for 20 min. The supernatants were stored at -70°C. Lysate protein was quantitated by using a commercial assay (Bio-Rad) with BSA as a reference standard.

Western blotting. Proteins (30 µg/sample) were separated by using SDS-polyacrylamide gel (7.5-12%) under denaturing conditions and electrotransferred onto nitrocellulose (Bio-Rad) for 1 h at 100 V. The membranes were blocked with 5% nonfat milk in Tris-buffered saline with 0.1% Tween 20 (TBST) overnight at 4°C. Primary antibodies were used in a 1:1,000 concentration in TBST with 5% nonfat milk for 2 h at room temperature. The Bcl-2 monoclonal antibody was obtained from PharMingen (San Diego, CA). The Bax antibody was polyclonal and was obtained from Oncogene (Cambridge, MA). Horseradish peroxidase-conjugated secondary antibodies were added in a 1:2,000 concentration for 1 h at room temperature. Films were developed by using the enhanced chemiluminescence method (Amersham, Arlington Heights, IL). beta -Actin controls were used for all Western blots, and densitometric results were adjusted accordingly.

Statistics. Data were collected from young adult and old rats that were subjected to LAD ligation and killed at the time points of 1, 3, and 5 h and 1 and 7 days after the procedure. At each time point, six young adult and six old animals were studied in the experimental group. There were 20 (10 young adult, 10 old) animals in the control group. The percentage of cells with DNA fragmentation in the ischemic-infarcted area was determined within each group. ANOVA was performed across the time points for the two age groups. For comparison at a single time point, the P value was calculated by use of the unpaired t-test. Bonferroni correction was applied to multiple comparisons. The Mann-Whitney nonparametric test was applied to infarct size for significance testing. P <=  0.05 was considered to be significant.

The means ± SD of the densitometric results of the proteins were used in a separate analysis. Mean control densitometric values within each age group were normalized to 1. Mean Bcl-2 and Bax normalized values for young and old were calculated for each time point. These values were then used to calculate a Bcl-2-to-Bax ratio for each age group. The control Bcl-2-to-Bax ratio was normalized to 1. ANOVA was applied to the protein ratios to assess age-related differences over time.

    RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

As shown in Fig. 1, LAD ligation resulted in an anterior wall infarction in the left ventricle. In all hearts of the experimental groups, there were clear histological features of recent ischemia and infarction, including neutrophil infiltration, eosinophilia, coagulation necrosis, and cellular edema. The estimated infarct size at 7 days, as percentage of the left ventricular myocardium, was 13.8 ± 3.7 in the young adult and 24.1 ± 2.3 in the old animals. The infarct size was significantly larger in the old compared with the young adult animals (P < 0.05).


View larger version (63K):
[in this window]
[in a new window]
 
Fig. 1.   Hematoxylin and eosin stain of section of left ventricle showing infarcted tissue at 7 days after left anterior descending coronary artery (LAD) ligation. A: old rat; B: young adult rat.

At baseline, there was a very low level of DNA fragmentation in the hearts of both young adult (Y) and old (O) rats (Y = 1.9 ± 0.5 × 10-5; O = 4.1 ± 0.4 × 10-5, P < 0.05), with the level being higher in the old hearts. After LAD occlusion, the DNA fragmentation in the nonischemic regions of the experimental hearts did not change significantly over time and remained similar to the baseline values within each age group (ANOVA: Y nonischemic across time, P = 0.13; O nonischemic across time, P = 0.14). The age-time interaction for the nonischemic controls was not significant (ANOVA: P = 0.39).

In the ischemic regions of the experimental hearts, DNA fragmentation was demonstrated to be increased in both young adult and old hearts (Figs. 2 and 3). Within each age group, there was a significant effect over time (ANOVA: Y, P < 0.04; O, P < 0.01). The age-time interaction was also significant (ANOVA: P < 0.001). At 3 h (Y3 = 3.7 ± 1.1; O3 = 7.8 ± 0.8; P < 0.002), the percentage of DNA fragmentation cells was higher in the old than in the young adult. In the old, it reached a peak at 3 h and remained elevated at 5 h (Figs. 2 and 3). In contrast to the old, the young adult heart sustained peak DNA fragmentation later, at 5 h (Y5 = 14.3 ± 2.1; O5 = 8.0 ± 3.2; P < 0.02). The degree of DNA fragmentation in both age groups was much lower at 1 day and was close to baseline at 7 days. There was no significant age-associated difference in DNA fragmentation at 1 or 7 days.


View larger version (116K):
[in this window]
[in a new window]
 
Fig. 2.   Detection of DNA strand breaks in myocyte nuclei by biotinylated dUTP labeling of left ventricular free wall (magnification ×200). A: young adult, 3 h postligation; B: young adult, 3 h postligation, double-stained with propidium iodide (red); C: young adult, 3 h postligation, double-stained with alpha -sarcomeric actin antibody; D: old, 3 h postligation; E: old, 3 h postligation, double-stained with propidium iodide (red); F: old, 3 h postligation, double-stained with alpha -sarcomeric actin antibody; G: young adult, 5 h postligation; H: young adult, 5 h postligation, double-stained with propidium iodide (red); I: young adult, 5 h postligation, double-stained with alpha -sarcomeric actin antibody; J: old, 5 h postligation; K: old, 5 h postligation, double-stained with propidium iodide (red); L: old, 5 h postligation, double-stained with alpha -sarcomeric actin antibody.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Percentage of cells with DNA fragmentation in heart after acute LAD ligation. Results shown are based on at least 3 separate experiments at each time point within each age group. * ANOVA, young adult vs. old, P < 0.02.

A DNA laddering pattern characteristic of DNA fragmentation was distinctly visible in the infarcted tissue in both age groups from 3 to 24 h after LAD ligation (Fig. 4). It was interesting that the fluorescent in situ end-labeling staining of cells with DNA fragmentation was visible in the heart as early as 1 h after LAD ligation. This was also detectable with DNA electrophoresis as demonstrated by a visible DNA laddering pattern at 1 h. However, a more intense DNA ladder was seen at 3 and 5 h.


View larger version (100K):
[in this window]
[in a new window]
 
Fig. 4.   Electrophoretic pattern of DNA fragments from hearts of young adult (6 mo; Y) and old (24 mo; O) rats. Control (CO) group was sham operated, and experimental myocardial infarction (MI) groups were subdivided into 1, 3, and 5 h and 1 and 7 days postsurgery. Molecular-weight markers (MW; 1-kb DNA ladder) were used. DNA ladder was visible at 1, 3, and 5 h and 1 day after LAD ligation.

Quantitative analysis of DNA fragmentation was performed by using the TUNEL method at the single-cell level. As the DNA was not radiolabeled, the DNA electrophoresis was not used for quantitative analysis but only to confirm the characteristic DNA fragmentation pattern associated with the apoptotic process. The variation in the intensity of the DNA ladder appeared to correlate with the quantitative estimation of DNA fragmentation as determined with the TUNEL technique.

At baseline, both Bcl-2 and Bax proteins were higher in the old than in the young adult hearts (P < 0.05, Figs. 5 and 6). Within each age group, the effect across time on Bcl-2 levels was only significant in young adult (ANOVA: Y, P < 0.02; O, P < 0.09). When the values at the various time points were normalized to the control values, Bcl-2 protein response to ischemia-infarction tended to be higher in the hearts of young adult compared with old rats after coronary occlusion (Fig. 7). Bax protein levels, however, were substantially lower in the old compared with young adult hearts during ischemia-infarction (P < 0.001, age-time interaction, repeated-measures ANOVA; Figs. 5-7). Within each age group, the effect across time on Bax levels was significant (ANOVA: Y, P < 0.05; O, P < 0.001).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 5.   Western blot of Bcl-2 and Bax protein expression in young and old hearts after coronary occlusion. n = 3 at each time point. SO, control; 3H, 3 h; 5H, 5 h; 1D, 1 day post-LAD ligation. Results shown are representative of 3 separate sets of experiments.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   Densitometric graphs of Bcl-2 (A) and Bax (B) protein expression in young and old hearts after coronary occlusion. n = 3 at each time point. Results shown are based on 3 separate sets of experiments. * Young adult vs. old, P < 0.05.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 7.   A: normalized Bcl-2 protein expression in rat hearts after coronary occlusion. Results are based on means ± SD of 3 separate experiments. n = 3 at each time point. Control values are normalized to 1. B: normalized Bax protein expression in rat hearts after coronary occlusion. Results are based on means ± SD of 3 separate experiments. n = 3 at each time point. Controls are normalized to 1. * Repeated-measures ANOVA, young adult vs. old, P < 0.001. C: ratio of normalized Bcl-2 to Bax protein expression in young and old rat hearts after coronary occlusion. Results are based on means ± SD of 3 separate experiments. n = 3 at each time point. Controls are normalized to 1. * Young adult vs. old, P < 0.02.

The ratio of Bcl-2 to Bax protein expression was determined at each time point by using values that were normalized to the control protein levels within each age group (Fig. 7). The normalized Bcl-2-to-Bax ratio was significantly higher after coronary occlusion in the old than in the young adult hearts (P < 0.02).

    DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

There are three major findings in this study. First, DNA fragmentation occurs within the first several hours after coronary occlusion and apparently peaks earlier in the old than in the young adult heart. Second, the basal levels of Bcl-2 and Bax are higher in the old than in the young adult heart. Third, ischemic stress results in higher anti- to pro-apoptotic protein ratios in the old compared with young adult heart.

A recent study of autopsy specimens from the human hearts after death due to acute myocardial infarction included patients between 58 and 93 yr old, but there was no age comparison per se (10). The infarcts were also >12 h old at autopsy, so that the study probably missed the period of acute evolution of the infarct, which occurs within the first 6-7 h. Other studies of human hearts during acute myocardial infarction suggest that apoptosis does occur and that it may provide a new target for designing cardioprotection during infarction (22, 24, 26, 27). One animal study investigated apoptosis vs. necrosis at different time points during infarction in adult rats and found that peak apoptosis occurred at around 4.5 h, whereas peak necrosis occurred at 24 h (14).

In the present study, the findings of DNA fragmentation being maximal in the young adult heart at 5 h are in agreement with that study (14). It is possible that transiently ischemic cardiomyocytes may undergo preferential apoptosis compared with cells that are supplied by completely occluded arteries, which tend to die some time later by necrosis (2, 5, 14, 27). These studies are noteworthy in that they demonstrate that not only can apoptosis occur extremely rapidly but that it may precede necrosis by several hours after coronary occlusion.

It is interesting that, in the present study, the percentage of apoptotic cells at 5 h was quantitatively greater in the young adult than in the old heart. One possible explanation for this finding might be that the hearts of old animals had higher apoptosis at baseline, a previously reported finding (15). In addition, it is likely that because the old heart is chronically exposed to some degree of ischemic stress at baseline, as reflected by higher levels of Bax protein at baseline, the cells in the older heart could have been preconditioned to undergo apoptosis earlier at 3 h (22). We were interested in focusing our study on apoptosis in young adult and old hearts because these cells may be potentially salvageable through targeted intervention. Moreover, the ratio of cells with apoptosis to necrosis after infarction has been well studied by others (14, 15).

In the present study, we were able to confirm the early onset of DNA fragmentation after acute LAD occlusion (2, 5, 14, 27). Our findings also demonstrated a highly significant age difference in the time course of DNA fragmentation after acute myocardial infarction. This may have potential bearing on the notion of the period of optimal clinical intervention in elderly patients with acute myocardial infarction. It is important to keep in mind the fact that other stimuli can also induce an apoptotic window, although on a different time frame. These stimuli include pressure overload in myocardial infarction (31) as well as hypertensive heart disease (8). It is therefore quite possible that a myocardial infarction would have a different effect on the DNA fragmentation process as well as the expression of pro- and anti-apoptotic genes in the hearts of older persons or animals due to the concomitant presence of atherosclerotic and/or hypertensive or other heart diseases.

The finding that peak DNA fragmentation occurred earlier in the old heart signifies perhaps a greater susceptibility to acute ischemic stress with advancing age. Other work in our laboratory involving the study of acute stress due to hypoxia-reoxygenation on the brain has shown that, compared with the brain of the young adult, the brain of the old animal is also more susceptible to DNA fragmentation after hypoxia-reoxygenation (18).

It is possible that increased protein expression of Bcl-2, an inhibitor of apoptosis, or decreased expression of Bax, an inducer of apoptosis, in the heart during ischemia or hypoxic injury could serve to reduce the extent of DNA fragmentation (13, 22). In the present study, both Bcl-2 and Bax protein levels at baseline were higher in the heart of the old compared with the young adult rat, perhaps indicative of a greater level of chronic stress in the old. This might explain the lower level of peak DNA fragmentation that occurred earlier in the older hearts. Despite a heightened stress response, the older hearts underwent earlier peak DNA fragmentation than that in the young adult. It is possible that a higher basal level of pro-apoptotic proteins such as Bax in the old heart might indicate prior ischemic stress and it might also have set the stage for earlier DNA fragmentation after cellular injury. It is also possible that the pro-apoptotic stimuli of increased Bax protein expression at baseline in the old heart could lead to a parallel increase in basal expression in the anti-apoptotic protein Bcl-2 (4).

In an effort to better understand the basis of the age differences in Bcl-2 and Bax expression, we sought to isolate the myocytes from the hearts of the young adult and old rats. However, with each isolation only a very few cardiomyocytes from the old hearts survived, and they were from the nonischemic areas of the heart. This would have made age comparisons of isolated myocytes problematic, since it would be difficult to extrapolate from a few isolated cells to the whole heart, especially when those cells would not have been representative of cells in the ischemic or peri-infarct area. Therefore a comparison using isolated myocytes from young adult vs. old hearts was not done. Nevertheless, we believe that our findings of age-associated differences using whole heart tissues from ischemic-peri-infarct regions of young adult vs. old hearts do make a contribution to the literature and are reflective of the pathophysiology of acute myocardial infarction in vivo.

It is known that the absolute levels of pro- or anti-apoptotic proteins do not necessarily correlate with cell death or survival. Rather, it is the ratio of pro- to anti-apoptotic proteins in a cell that probably determines its fate (22, 27). It is interesting that in the old rat heart the level of Bax expression is so significantly suppressed at 3 h, whereas Bcl-2 rises above basal levels at that time. The reasons for this are not entirely clear but may involve the production of other anti-apoptotic factors that may repress Bax expression. Future studies will help to elucidate these facts.

It was interesting that the ratio of pro- to anti-apoptotic proteins is clearly in favor of Bcl-2 in the old hearts at 3 h. The fact that DNA fragmentation in the old hearts appeared to peak at 3 h when the Bcl-2-to-Bax ratio is also maximal, can be explained by the fact that a lag time exists between the ratio of Bcl-2 to Bax expression and DNA fragmentation. The DNA fragmentation that was measured is indicative of cumulative DNA fragmentation between 1 and 3 h, and the process of DNA fragmentation usually occurs later than that of Bcl-2 and Bax expression. Furthermore, it is quite possible that the reason the DNA fragmentation peaked at 3 h and did not rise further at 5 h in the old heart was because of the elevated Bcl-2-to-Bax ratio which peaked at 3 h and thereby served to limit the DNA fragmentation in the old hearts.

There are several limitations in this experiment. The focus of the present study was to evaluate in vivo age-associated changes in whole heart tissue in response to acute ischemic stress. We did not study the cell type-specific responses. Further efforts to define how age differences in myocardial response are reflective of changes in myocyte vs. fibroblast activity would be of interest. It is possible that a different ischemic stress threshold might exist for the different cell types in the heart, with cardiomyocytes being more sensitive than fibroblasts. However, demonstration of this difference will require separate in vitro and in vivo studies. It should be noted also that the in situ end-labeling method of DNA labeling has its limitations and preferentially detects double-strand DNA breaks in cells undergoing apoptosis. It is possible that a percentage of single-strand DNA breaks in preapoptotic cells were missed. The present study was focused on the protein expression of Bcl-2 and Bax because of the tight association and ratio that these two proteins have in mediating cellular apoptosis. A number of other proteins that are also important in cellular apoptosis, including p53, p21WAF, and c-Myc, were not characterized in this study (1, 6, 12, 19). Future studies to pursue these other proteins would probably be informative. Further work to evaluate possible age-related differences in neutrophilic response to injury will also be of interest (3, 7, 20, 23, 25).

Perspectives

The underlying reasons for a greater degree of cellular stress in the old heart are likely to be multifactorial and will require detailed studies. It is conceivable, however, that one might be able to potentially alter the ratio of pro- and anti-apoptotic proteins to thereby increase the resilience of the older heart during ischemic stress. The molecular mechanisms of the differential rate of DNA fragmentation between the young adult and old hearts merit further investigation. Needless to say, an understanding of these mechanisms will probably help in the design of future therapies intended to reduce the consistently higher morbidity and mortality associated with acute myocardial ischemia-infarction in the elderly population.

    ACKNOWLEDGEMENTS

We thank Isaac Stillman MD for helpful advice, Jeffrey M. Hausdorff PhD for statistical assistance, and David Knauss for manuscript preparation.

    FOOTNOTES

This work was partially supported by National Institute on Aging Grants AG-10829, AG-00294, AG-08812, AG-13314, and AG-00251.

Address for reprint requests: J. Y. Wei, Gerontology Div., Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA 02215.

Received 1 July 1997; accepted in final form 20 March 1998.

    REFERENCES
Top
Abstract
Introduction
Methods
Results
Discussion
References

1.   Bialik, S., D. L. Geenen, I. E. Sasson, R. Cheng, J. W. Horner, S. E. Evans, E. M. Lord, C. J. Koch, and R. N. Kitsis. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J. Clin. Invest. 100: 1363-1372, 1997[Medline].

2.   Cheng, W., J. Kajstura, J. A. Nitahara, B. Li, K. Reiss, Y. Liu, W. A. Clark, S. Krajewski, J. C. Reed, G. Olivetti, and P. Anversa. Programmed myocyte cell death affects the myocardium after infarction in rats. Exp. Cell Res. 226: 316-327, 1996[Medline].

3.   Dunford, H. B. One-electron oxidations by peroxidases. Xenobiotica 25: 725-733, 1995[Medline].

4.   Fernandez, A., M. C. Marin, T. McDonnell, and H. N. Ananthaswamy. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: induction of Bcl-2, c-myc, and manganese superoxide dismutase in resistant cells. Oncogene 9: 2009-2017, 1994[Medline].

5.   Fliss, H., and D. Gattinger. Apoptosis in ischemic and reperfused rat myocardium. Circ. Res. 79: 949-956, 1996[Abstract/Free Full Text].

6.   Gorospe, M., C. Cirielli, X. Wang, P. Seth, M. C. Capogrossi, and N. J. Holbrook. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 14: 929-935, 1997[Medline].

7.   Gottlieb, A., K. O. Burleson, R. A. Kloner, B. M. Babior, and R. L. Engler. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94: 1621-1628, 1994.

8.   Hamet, P., P. Moreau, T. V. Dam, S. N. Orlov, B. S. Tea, D. de Blois, and J. Tremblay. The time window of apoptosis: a new component in the therapeutic strategy for cardiovascular remodeling. J. Hypertens. Suppl. 14: S65-S70, 1996[Medline].

9.   Heinecke, J. W., W. Li, H. L. Daehnke III, and J. A. Goldstein. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 268: 4069-4077, 1993[Abstract/Free Full Text].

10.   Itoh, G., J. Tamura, M. Suzuki, Y. Suzuki, H. Ikeda, M. Koike, M. Nomura, T. Jie, and K. Ito. DNA fragmentation of human infarcted myocardial cells demonstrated by the Nick end labeling method and DNA agarose gel electrophoresis. Am. J. Pathol. 146: 1325-1331, 1995[Abstract].

11.   James, T. N. Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation 90: 556-573, 1994[Abstract/Free Full Text].

12.   Kagaya, S., C. Kitanaka, K. Noguchi, T. Mochizuki, A. Sugiyama, A. Asai, N. Yasuhara, Y. Eguchi, Y. Tsujimoto, and Y. Kuchino. A functional role for death proteases in s-Myc- and c-Myc-mediated apoptosis. Mol. Cell. Biol. 17: 6736-6745, 1997[Abstract].

13.   Kagisaki, K., H. Ichikawa, R. Shirakura, and H. Matsuda. Hypoxia induces DNA damage in adult cardiomyocytes: evidence for hypoxia induced apoptosis (Abstract). Circulation 92: I-772, 1996.

14.   Kajstura, J., W. Cheng, K. Reiss, W. A. Clark, E. H. Sonnenblick, S. Krajewski, J. C. Reed, G. Olivetti, and P. Anversa. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab. Invest. 74: 86-107, 1996[Medline].

15.   Kajstura, J., W. Cheng, R. Sarangarajan, P. Li, B. Li, J. A. Nitahara, S. Chapnick, K. Reiss, G. Olivetti, and P. Anversa. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1215-H1228, 1996[Abstract/Free Full Text].

16.   Kajstura, J., M. Mansukhani, W. Cheng, K. Reiss, S. Krajewski, J. C. Reed, F. Quaini, E. H. Sonnenblick, and P. Anversa. Programmed cell death and expression of the protooncogene Bcl-2 in myocytes during postnatal maturation of the heart. Exp. Cell Res. 219: 110-121, 1995[Medline].

17.   Lesnefsky, E. J., C. F. Lundergan, J. M. Hodgson, R. Nair, J. S. Reiner, S. W. Greenhouse, R. M. Califf, and A. M. Ross. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience. J. Am. Coll. Cardiol. 28: 331-337, 1996[Abstract].

18.   Liu, L., G. Azhar, X.-M. Zhang, S. W. Lee, and J. Y. Wei. Influence of age on hypoxia-induced apoptosis and gene expression in the adult rat brain and heart (Abstract). Gerontologist 36: 294, 1996.

19.   Long, X., M. O. Boluyt, M. L. Hipolito, M. S. Lundberg, J. S. Zheng, L. O'Neill, C. Cirielli, E. G. Lakatta, and M. T. Crow. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J. Clin. Invest. 99: 2635-2643, 1997[Medline].

20.   Marquez, L. A., and H. B. Dunford. Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. Implications for lipoprotein peroxidation studies. J. Biol. Chem. 270: 30434-30440, 1995[Abstract/Free Full Text].

21.   Meikrantz, W., and R. Schlegel. Apoptosis and the cell cycle. J. Cell. Biochem. 58: 160-174, 1995[Medline].

22.   Misao, J., Y. Hayakawa, O. Michiya, S. Kato, T. Fujiwara, and H. Fujiwara. Expression of Bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 94: 1506-1512, 1996[Abstract/Free Full Text].

23.   Murohara, T., J. P. Guo, and A. M. Lefer. Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury. J. Pharmacol. Exp. Ther. 274: 1246-1253, 1995[Abstract/Free Full Text].

24.   Narula, J., N. Haider, R. Virmani, T. G. DiSalvo, F. D. Kolodgie, R. J. Hajjar, U. Schmidt, M. J. Semigran, G. W. Dec, and B.-A. Khaw. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335: 1182-1189, 1996[Abstract/Free Full Text].

25.   O'Brien, P. J. Radical formation during the peroxidase catalyzed metabolism of carcinogens and xenobiotics: the reactivity of these radicals with GSH, DNA, and unsaturated lipid. Free Radic. Biol. Med. 4: 169-183, 1988[Medline].

26.   Olivetti, G., F. Quaini, R. Sala, C. Lagrasta, D. Corradi, E. Bonacina, S. R. Gambert, E. Cigola, and P. Anversa. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J. Mol. Cell. Cardiol. 28: 2005-2016, 1996[Medline].

27.   Saraste, A., K. Pulkki, M. Kallajoki, K. Henriksen, M. Parvinen, and L.-M. Voipio-Pulkki. Apoptosis in human acute myocardial infarction. Circulation 95: 320-323, 1997[Abstract/Free Full Text].

28.   Schmitz, G. G., T. Walter, R. Seibl, and C. Kessler. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal. Biochem. 192: 222-231, 1991[Medline].

29.   Schwartz, S. M., and M. R. Bennett. Death by any other name. Am. J. Pathol. 147: 229-234, 1995[Medline].

30.   Steller, H. Mechanisms and genes of cellular suicide. Science 267: 1445-1449, 1995[Abstract/Free Full Text].

31.   Teiger, E., V. D. Than, L. Richard, C. Wisnewsky, B. S. Tea, L. Gaboury, J. Tremblay, K. Schwartz, and P. Hamet. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J. Clin. Invest. 97: 2891-2897, 1996[Medline].

32.   Wei, J. Y. Age and the cardiovascular system. N. Engl. J. Med. 327: 1735-1739, 1992[Medline].


Am J Physiol Regul Integr Compar Physiol 275(1):R315-R322
0002-9513/98 $5.00 Copyright © 1998 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
Q. Chen, A. K. S. Camara, D. F. Stowe, C. L. Hoppel, and E. J. Lesnefsky
Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C137 - C147.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Zhang, J. L. Mott, S.-W. Chang, M. Stevens, P. Mikolajczak, and H. P. Zassenhaus
Mitochondrial DNA mutations activate programmed cell survival in the mouse heart
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2476 - H2483.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. C. Sparagna, C. E. Jones, and D. L. M. Hickson-Bick
Attenuation of fatty acid-induced apoptosis by low-dose alcohol in neonatal rat cardiomyocytes
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2209 - H2215.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Liu, C. C. Chua, J. Gao, Z. Chen, C. L. C. Landy, R. Hamdy, and B. H. L. Chua
Pifithrin-{alpha} protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H933 - H939.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Cai, M. Xaymardan, J. M. Holm, J. Zheng, J. R. Kizer, and J. M. Edelberg
Age-associated impairment in TNF-{alpha} cardioprotection from myocardial infarction
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H463 - H469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Hochhauser, S. Kivity, D. Offen, N. Maulik, H. Otani, Y. Barhum, H. Pannet, V. Shneyvays, A. Shainberg, V. Goldshtaub, et al.
Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2351 - H2359.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Chen, C. C. Chua, Y.-S. Ho, R. C. Hamdy, and B. H. L. Chua
Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2313 - H2320.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Yamamura, H. Otani, Y. Nakao, R. Hattori, M. Osako, and H. Imamura
IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1191 - H1200.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. He, Y. Xiao, C. A. Casiano, and L. Zhang
Role of Mitochondrial Cytochrome c in Cocaine-Induced Apoptosis in Coronary Artery Endothelial Cells
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 896 - 903.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
P. M. Kang and S. Izumo
Apoptosis and Heart Failure : A Critical Review of the Literature
Circ. Res., June 9, 2000; 86(11): 1107 - 1113.
[Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. LYN, X. LIU, N. A. BENNETT, and N. L. EMMETT
Gene expression profile in mouse myocardium after ischemia
Physiol Genomics, April 27, 2000; 2(3): 93 - 100.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
N. Gotoh, K. Kambara, X.-W. Jiang, M. Ohno, S. Emura, T. Fujiwara, and H. Fujiwara
Apoptosis in microvascular endothelial cells of perfused rabbit lungs with acute hydrostatic edema
J Appl Physiol, February 1, 2000; 88(2): 518 - 526.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. A. Cook, P. H. Sugden, and A. Clerk
Regulation of Bcl-2 Family Proteins During Development and in Response to Oxidative Stress in Cardiac Myocytes : Association With Changes in Mitochondrial Membrane Potential
Circ. Res., November 12, 1999; 85(10): 940 - 949.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Yang, D. F. Larson, and R. Watson
Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1906 - H1913.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, L.
Right arrow Articles by Wei, J. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, L.
Right arrow Articles by Wei, J. Y.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online